Apollo Hospitals Enterprise Limited completed the acquisition of remaining 50% stake in Apollo Gleneagles Pet Ct Pvt Ltd from Parkway Holdings Limited.
Apollo Hospitals Enterprise Limited (NSEI:APOLLOHOSP) agreed to acquire remaining 50% stake in Apollo Gleneagles Pet Ct Pvt Ltd from Parkway Holdings Limited for INR 85 million on August 12, 2025. Upon completion, Apollo Hospitals Enterprise Limited will own 100% stake in Apollo Gleneagles Pet Ct Pvt Ltd.
For the period ending March 31, 2025, Apollo Gleneagles Pet Ct Pvt Ltd reported total revenue of INR 202 million.
The transaction is subject to completion of customary closing formalities and approval of offer by acquirer board. The acquirer board has approved the transaction. The expected completion of the transaction is by end of August 2025.
Apollo Hospitals Enterprise Limited (NSEI:APOLLOHOSP) completed the acquisition of remaining 50% stake in Apollo Gleneagles Pet Ct Pvt Ltd from Parkway Holdings Limited on October 3, 2025. Siddharth Mody and Rohan Kumar of J. Sagar Associates acted as legal advisors for Parkway Holdings Limited.
Apollo Hospitals Enterprise Limited specializes in healthcare services. Net sales break down by activity as follows:
- hospital and outpatient surgical care services (54.6%): exploitation of a network of 71 hospitals (9,911 beds) at the end of March 2022;
- distribution of pharmaceutical and wellness products (36.5%): exploitation of a network of 4,529 pharmacies in India;
- healthcare and diagnostic services (8.9%): exploitation of 254 primary care clinics, 1,228 diagnostic centers, 90 dialysis centers, 95 dental clinics, 29 diabetes management clinics, 15 obstetric and pediatric clinics and 11 specialized care centers.
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Apollo Hospitals Enterprise Limited completed the acquisition of remaining 50% stake in Apollo Gleneagles Pet Ct Pvt Ltd from Parkway Holdings Limited.
